Morgan Stanley (MS) recently demonstrated strong market outperformance, gaining 1.42% in the latest session and 6.29% previously, significantly exceeding broader market indices. The firm is anticipated to report robust Q2 2025 results on July 16, with consensus estimates projecting a 9.89% year-over-year EPS increase to $2 and 6.36% revenue growth to $15.97 billion. While its Forward P/E of 15.64 indicates a slight premium to the industry average, its PEG ratio of 1.22 is below its industry average, and the stock currently holds a Zacks Rank of #3 (Hold) despite a marginal downward revision in recent EPS projections.
Morgan Stanley (MS) has demonstrated significant recent market outperformance, with its shares gaining 6.29% over a recent period, easily surpassing the S&P 500's 3.92% increase. Investor focus is now on the upcoming July 16, 2025, earnings release, for which consensus estimates project robust year-over-year growth: a 9.89% rise in EPS to $2.00 and a 6.36% increase in revenue to $15.97 billion. This positive outlook is tempered by a minor 0.1% downward revision in the consensus EPS forecast over the past 30 days, contributing to its current Zacks Rank of #3 (Hold). From a valuation perspective, MS trades at a forward P/E of 15.64, a slight premium to its industry's 15.02 average. However, its PEG ratio of 1.22 is slightly below the industry average of 1.26, suggesting its growth prospects are reasonably priced. The company also benefits from operating in an industry ranked in the top 40% of over 250 sectors, indicating a healthy backdrop.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment